Results 181 to 190 of about 105,862 (321)

Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis

open access: yesEuropean Journal of Neurology, Volume 30, Issue 1, Page 162-171, January 2023., 2023
Abstract Background and purpose Data on pregnancy outcomes following fetal exposure to disease‐modifying drugs (DMDs) in women with multiple sclerosis (MS) are sparse although growing. Methods Data from the Danish Multiple Sclerosis Registry were linked with nationwide registries enabling an investigation of adverse pregnancy outcomes in newborns of ...
Johanna Balslev Andersen   +2 more
wiley   +1 more source

EVALUATION OF NEONATAL OUTCOME BY MEASURING UMBILICAL ARTERY BLOOD PH VALUE

open access: yesZdravniški Vestnik, 2002
Background. The evaluation of neonatal outcome after delivery is being performed since 1953 by Apgar score. Since some parts of this scoring system subject to personal judgment of the evaluator, the researchers attempts are to introduce more objective ...
Frenk Krištofelc
doaj  

Planning postpartum contraception for women with substance use disorders: Utilisation of the birth admission

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Women with substance use disorders (SUD) use less contraception, and experience higher rates of unintended pregnancy, compared to women without SUD. Contraception is discussed at the six‐week postnatal appointment, which many women with SUD do not attend.
Kelly A. McNamara   +6 more
wiley   +1 more source

A gain‐of‐function GRIA2 variant associated with neurodevelopmental delay and seizures: Functional characterization and targeted treatment

open access: yesEpilepsia, Volume 63, Issue 12, Page e156-e163, December 2022., 2022
Abstract α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid‐type glutamate receptors (AMPARs) are ligand‐gated cationic channels formed from combinations of GluA1‐4 subunits. Pathogenic variants of GRIA1–4 have been described in patients with developmental delay, intellectual disability, autism spectrum disorder, and seizures, with GRIA2 variants ...
Ian D. Coombs   +5 more
wiley   +1 more source

Apgar score in the United States, 1978 [PDF]

open access: yes
The Apgar score was developed in 1952 by Virginia Apgar, M.D., as a means of evaluating the physical condition of an infant at 1 and 5 minutes after birth.

core  

The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Cannabis use during pregnancy is becoming more prevalent. While numerous studies have explored the relationship of cannabis use during pregnancy and outcomes for mothers and infants, uncertainty remains regarding the impact of cannabis use on pregnancy complications and later‐life outcomes for offspring.
Zachary Munn   +7 more
wiley   +1 more source

APGAR SCORE OF NEONATE

open access: bronze, 2006
Aneel Aslam, Fawad Alam, ADEEL ASLAM
openalex   +2 more sources

Apgar scores at 10 min and outcomes at 6–7 years following hypoxic-ischaemic encephalopathy [PDF]

open access: green, 2013
Girija Natarajan   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy